Pomalidomide Myeloma Trials

SparkCures ID	5
Developed By	Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb
Brand Name	Pomalyst^®
Generic Name	Pomalidomide
Additional Names	CC-4047, Actimid
Treatment Classifications	Immunomodulatory Drug (IMiD)

All Clinical Trials

View all active clinical trials around the US.

Verified

Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...

MONUMENTAL-3

View Trial

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...

LINKER-MM3

View Trial

Verified

Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Mul...

ALUMMINATE RRMM

View Trial

Verified

A Phase 3, Open-Label Study of Elranatamab Monotherapy Versus Elotuzumab, Pomalidomide, Dexamethasone (EPd) Or Pomalidomide, Bortezomib, Dexamethasone (PVd) ...

MAGNETISMM-32

View Trial

Verified

A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Parti...

MAJESTEC-9

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

Phase 3 Study Evaluating Subcutaneous vs Intravenous Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractor...

IRAKLIA

View Trial

Verified

Phase 1B Clinical Trial Studying the Safety, Activity, and Effectiveness of Cevostamab in Treating People with Relapsed or Refractory Multiple Myeloma

CAMMA-1

View Trial

Verified

A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...

DREAMM8

View Trial

Verified

Multicenter, Open-label, Single-arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Pomalidomide, Dexamethasone, and Carfilzomib (...

CARFILZOMIB COMBINATION THERAPY

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

Verified

A Study of Belantamab Mafodotin in Combination With and Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or ...

BELANTAMAB MAFODOTIN COMBINATION THERAPY

View Trial

Verified

Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Mu...

DREAMM5

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

BELANTAMAB MAFODOTIN COMBINATION THERAPY

View Trial

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...

ISATUXIMAB COMBINATION THERAPY

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISATUXIMAB COMBINATION THERAPY

View Trial

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

PERSONALIZED SELINEXOR-BASED THERAPY

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

Marizomib Central Nervous System (CNS)

MARIZOMIB FOR MYELOMA PATIENTS WITH CNS

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-383 in C...

ABBV-383

View Trial

A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma

MONUMENTAL-2

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma

IXAZOMIB COMBINATION THERAPY

View Trial

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...

SCOPE

View Trial

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified

Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...

MONUMENTAL-3

View Trial

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...

LINKER-MM3

View Trial

Verified

Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Mul...

ALUMMINATE RRMM

View Trial

Verified

A Phase 3, Open-Label Study of Elranatamab Monotherapy Versus Elotuzumab, Pomalidomide, Dexamethasone (EPd) Or Pomalidomide, Bortezomib, Dexamethasone (PVd) ...

MAGNETISMM-32

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

Phase 3 Study Evaluating Subcutaneous vs Intravenous Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractor...

IRAKLIA

View Trial

Verified

Phase 1B Clinical Trial Studying the Safety, Activity, and Effectiveness of Cevostamab in Treating People with Relapsed or Refractory Multiple Myeloma

CAMMA-1

View Trial

Verified

A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...

DREAMM8

View Trial

Verified

Multicenter, Open-label, Single-arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Pomalidomide, Dexamethasone, and Carfilzomib (...

CARFILZOMIB COMBINATION THERAPY

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...

ISATUXIMAB COMBINATION THERAPY

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISATUXIMAB COMBINATION THERAPY

View Trial

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

PERSONALIZED SELINEXOR-BASED THERAPY

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

Marizomib Central Nervous System (CNS)

MARIZOMIB FOR MYELOMA PATIENTS WITH CNS

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma

IXAZOMIB COMBINATION THERAPY

View Trial

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...

SCOPE

View Trial

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...

MONUMENTAL-3

View Trial

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...

LINKER-MM3

View Trial

Verified

Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Mul...

ALUMMINATE RRMM

View Trial

Verified

A Phase 3, Open-Label Study of Elranatamab Monotherapy Versus Elotuzumab, Pomalidomide, Dexamethasone (EPd) Or Pomalidomide, Bortezomib, Dexamethasone (PVd) ...

MAGNETISMM-32

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

Phase 3 Study Evaluating Subcutaneous vs Intravenous Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractor...

IRAKLIA

View Trial

Verified

Phase 1B Clinical Trial Studying the Safety, Activity, and Effectiveness of Cevostamab in Treating People with Relapsed or Refractory Multiple Myeloma

CAMMA-1

View Trial

Verified

A Phase III Study of Belantamab Mafodotin plus Pomalidomide and Dexamethasone vs Pomalidomide, Bortezomib and Dexamethasone in Participants with Relapsed / R...

DREAMM8

View Trial

Verified

Multicenter, Open-label, Single-arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Pomalidomide, Dexamethasone, and Carfilzomib (...

CARFILZOMIB COMBINATION THERAPY

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

Verified

A Study of Belantamab Mafodotin in Combination With and Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or ...

BELANTAMAB MAFODOTIN COMBINATION THERAPY

View Trial

Verified

Platform Study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Mu...

DREAMM5

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...

ISATUXIMAB COMBINATION THERAPY

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISATUXIMAB COMBINATION THERAPY

View Trial

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

PERSONALIZED SELINEXOR-BASED THERAPY

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

Marizomib Central Nervous System (CNS)

MARIZOMIB FOR MYELOMA PATIENTS WITH CNS

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Ixazomib + Pomalidomide + Dexamethasone In Multiple Myeloma

IXAZOMIB COMBINATION THERAPY

View Trial

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With R...

SCOPE

View Trial

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

Pomalidomide

POMALYST®

Overview

Clinical Trials

Resources

POMALYST^®